DNA Methylation of <i>FKBP5</i> as Predictor of Overall Survival in Malignant Pleural Mesothelioma

DNA Methylation of <i>FKBP5</i> as Predictor of Overall Survival in Malignant Pleural Mesothelioma

Malignant pleural mesothelioma (MPM) is an aggressive tumor with median survival of 12 months and limited effective treatments. The scope of this study was to study the relationship between blood DNA methylation (DNAm) and overall survival (OS) aiming at a noninvasive prognostic test. We investigate...

Full description

Bibliographic Details
Main Authors: Giovanni Cugliari, Chiara Catalano, Simonetta Guarrera, Alessandra Allione, Elisabetta Casalone, Alessia Russo, Federica Grosso, Daniela Ferrante, Clara Viberti, Anna Aspesi, Marika Sculco, Chiara Pirazzini, Roberta Libener, Dario Mirabelli, Corrado Magnani, Irma Dianzani, Giuseppe Matullo
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
malignant pleural mesothelioma
asbestos exposure
DNA methylation
lymphocyte-to-monocyte ratio
epigenome-wide analysis
survival analysis
Online Access:https://www.mdpi.com/2072-6694/12/11/3470

Internet

https://www.mdpi.com/2072-6694/12/11/3470

Similar Items